课题基金 / 基金详情

Nitron derivatives to Blatter radicals: novel anti-cancer pro-drugs and mechanistic probes

Nitron derivatives to Blatter radicals: novel anti-cancer pro-drugs and mechanistic probes
布拉特自由基的硝基衍生物:新型抗癌前药和机制探针
批准号:
2214221
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
New, selective cancer treatments continue to be a major focus of the pharmaceutical and other life science industries. We will harness a recently-discovered facile reaction of the simple heterocycle Nitron to give isolable benzotriazinyl ('Blatter') radicals, which have been implicated as cytotoxic DNA-damaging species in the mechanism of action of Tirapazamine (a selective cancer drug currently in clinical trials). The direct biological evaluation of a broad range of novel Blatter radicals will provide a previously unexplored, unique mechanistic probe of the origin of tirapazamine cytotoxicity. In addition, Nitron and synthetic derivatives will be explored as alternative pro-drugs to tirapazamine for in situ access to benzotriazinyl species.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
英文专著《FRACTIONAL INTEGRALS AND DERIVATIVES: Theory and Applications》的翻译
  • 批准号:
    12126512
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2021
  • 负责人:
    李常品
  • 依托单位: